|
Thomas D. Schiano, M.D., is an American specialist in liver transplantation, intestinal transplantation and in the diagnosis and treatment of acute and chronic liver disease. He serves as Associate Editor for the journals ''Hepatology'' and ''Liver Transplantation'' and has published more than 200 peer-reviewed articles and abstracts and more than 20 book chapters. Schiano is currently Professor of Medicine at the Mount Sinai School of Medicine as well as the Medical Director of Adult Liver Transplantation, Medical Director of Intestinal Transplantation and Director of Clinical Hepatology at the Recanati/Miller Transplantation Institute at the Mount Sinai Medical Center in New York City.〔〔(【引用サイトリンク】title=doctorpage.com )〕 He is listed among New York Magazine's Best Doctors, as well as among the New York Times Magazine's list of Super Doctors 2008 -2011. ==Biography== Schiano was born in Brooklyn, New York. He graduated from Fordham University with a B.S. in biology and a minor in philosophy in 1979 and received his M.D. from Universidad Del Noreste Medical School in Tampico, Mexico in 1983.〔 His residency and chief residency in internal medicine were completed at Maimonides Medical Center and he completed fellowships at Memorial Sloan-Kettering (in clinical nutrition), Temple University Hospital (in gastroenterology), and Mount Sinai Hospital (in liver disease and liver transplantation). Schiano is a member of the American Association for the Study of Liver Diseases, the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, the New York Organ Donor Network〔(【引用サイトリンク】title=New York Organ Donor Network )〕 and the American Society of Transplantation. Areas of research include liver transplantation, living donor liver transplantation, herbal and drug hepatotoxicity, nutrition and liver disease, cirrhosis, intestinal transplantation, recurrence of disease post-liver transplantation, treatment of viral hepatitis post-liver transplantation, herbal and alternative treatments of chronic liver disease, complications of cirrhosis, portal hypertension, and cholestasis associated with TPN.〔〔 Schiano is the currently a Principal Investigator on clinical trial A Rollover Protocol to Provide Open-Label Emtricitabine/Tenofovir Disoproxil Fumarate Combination Product to Subjects Completing the GS-US-203-0107 Study, Protocol GS-US-203-0109. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Thomas D. Schiano」の詳細全文を読む スポンサード リンク
|